PromiCell, Inc. presents during JP Morgan’s 2026 Healthcare Conference Clinical Trials January 10, 2026 PromiCell, Inc. (the Company), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients,…
